Flora Growth(FLGC)

Search documents
Flora Growth Corp. Reports Second Quarter 2024 Financial Results
Newsfile· 2024-08-12 21:05
Fort Lauderdale, Florida--(Newsfile Corp. - August 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") reported today its financial and operating results for the three and six months ended June 30, 2024. "In the second quarter of 2024, we at Flora, demonstrated an aptitude to make accretive acquisitions and form strategic partnerships to capitalize on the most robust market trends. In Germany, we acquired TruHC Pharma GmbH in response to the de-scheduling of cannabis, the re ...
Flora Growth(FLGC) - 2024 Q2 - Quarterly Report
2024-08-12 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number 000-52776 Flora Growth Corp. (Exact name of registrant as specified in its charter) Province of Ontario Not ...
Flora Growth Celebrates National CBD Day
Newsfile· 2024-08-08 13:20
Fort Lauderdale, Florida--(Newsfile Corp. - August 8, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") proudly celebrates National CBD Day, a day dedicated to recognizing the vast benefits and rapid growth of the CBD industry in the United States and beyond. National CBD Day not only celebrates the therapeutic benefits of cannabidiol ("CBD") but also serves as a reminder of the political strides made in recent years. Legislative bodies across various states have increasingly ...
Flora Growth Announces Frankfurt Stock Exchange Listing
Newsfile· 2024-08-07 20:31
Fort Lauderdale, Florida--(Newsfile Corp. - August 7, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce that the Company's common shares now trade on the Frankfurt Stock Exchange ("FSE") under the symbol "7301". The Frankfurt Stock Exchange is one of the world's largest (behind only the Nasdaq and NYSE) organized exchange-trading market in terms of turnover and dealings with securities. The electronic trading platform of the FSE, XETRA, has made it the w ...
Flora Growth Announces Launch of New Calm and Sleep Gummies
Newsfile· 2024-08-06 13:20
● . Flora Growth Announces Launch of New Calm and Sleep Gummies August 06, 2024 9:20 AM EDT | Source: Flora Growth Corp. Fort Lauderdale, Florida--(Newsfile Corp. - August 6, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company")'s JustCBD, a leading consumer products brand, is excited to introduce two new products to its line of offerings - JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies and JustCBD+ Sleep Magnesium and Melatonin Raspberry Gummies. These innovative gummies are ...
Flora Growth Corp. Closes Acquisition of Australian Vaporizers
Newsfile· 2024-06-05 13:20
Fort Lauderdale, Florida--(Newsfile Corp. - June 5, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company") has entered into a share purchase agreement (the "Agreement") to acquire of all of the issued and outstanding shares of Australian Vaporizers Pty Limited ("Australian Vaporizers") in exchange for 550,000 Flora common shares, valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The transaction closed on June 4, ...
Flora Growth(FLGC) - 2024 Q1 - Quarterly Report
2024-05-14 21:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number 000-52776 3230 W. Commercial Boulevard, Suite 180 Fort Lauderdale, Florida 33309 (Address of principal exe ...
Flora Growth(FLGC) - 2023 Q4 - Annual Report
2024-03-28 20:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________ FORM 10-K _________________________ (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023. OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________. | --- | --- | --- | |--------------------------------------------------------------------- ...
Flora Growth(FLGC) - 2023 Q3 - Quarterly Report
2023-11-07 16:00
Non-currentoperatingleaseliability-308 Totalliabilitiesheldforsale$374$918 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------|-----------------------------------------|-----------------------|-------|---------------------------------------------------------------|-------|--------------------------------------------------------------|--------------|--------------------------------------------------------| | Revenue | For the mon ...
Flora Growth(FLGC) - 2023 Q2 - Earnings Call Transcript
2023-08-15 15:59
Financial Data and Key Metrics - Q2 2023 revenue was $21.5 million, a 140% increase compared to Q2 2022 [15] - H1 2023 revenue was $40.8 million, a 210% year-over-year increase [15] - Q2 2023 gross profit was $4.0 million, a 19% increase compared to Q2 2022 [15] - H1 2023 gross profit was $9.3 million, a 68% year-over-year increase [15] - Q2 2023 net loss was $44.6 million, primarily due to impairment expenses of $34.9 million, loss from discontinued operations of $7.6 million, and non-cash expenses of $1.2 million [17] - H1 2023 net loss was $48.5 million, consisting of impairment expenses of $34.9 million, loss from discontinued operations of $8.3 million, and non-cash expenses of $2.7 million [17] Business Line Data and Key Metrics - Just Brands operates in all 50 US states, 21 countries, and over 20,000 distribution points globally, offering products like gummies, Delta 8, and HHC [10] - Vessel is a leading brand in consumer technology, including vape pens, batteries, and accessories, with a premium product base and high customer loyalty [11] - Phatebo is a German-based distributor of patented brand pharmaceuticals, reaching 28 countries, with potential to become a key player in cannabis therapeutics in Europe [11] Market Data and Key Metrics - The global financial markets downturn, particularly in the cannabis sector, continues to challenge the industry [12] - The company remains optimistic about the long-term prospects of the cannabis sector, emphasizing the need for consolidation, cost reduction, and efficient business models [12] Company Strategy and Industry Competition - The company divested its Colombian operations and implemented $6.1 million in cost savings, including significant reductions in corporate overhead [8] - The company is focusing on cash flow diversity and growth in core businesses, which are expected to remain cash flow positive [9] - The company plans to continue cost-cutting and resource optimization without sacrificing performance [14] - The company is seeking additional financing to improve liquidity, viewing the current market as a generational opportunity for investment in the sector [18] Management Commentary on Operating Environment and Future Outlook - The company believes favorable regulatory outcomes for adult-use cannabis in the US and Europe could deliver significant upside in the future [9] - The company is confident in its trajectory and committed to delivering value to shareholders [18] Other Important Information - Just Brands formed an exclusive worldwide partnership with Hulk Hogan to produce and sell branded products, expected to be accretive to Flora [3] - The company expects to form additional partnerships with entertainers and celebrities in the near future [3] Q&A Session - No questions were asked during the Q&A session [20]